Shopping Cart
Remove All
Your shopping cart is currently empty
VEGF165 Protein, Human/Cynomolgus, Recombinant V2
(Synonyms: VPF, VEGFA, VEGF, Vascular permeability factor, L-VEGF) Copy Product InfoSynonyms: VPF, VEGFA, VEGF, Vascular permeability factor, L-VEGF
Catalog No. TMPY-01041U Copy Product Info
VEGF165 Protein, Human/Cynomolgus, Recombinant V2 is expressed in HEK293 Cells. The accession number is P15692-4.
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 µg | $112 | 7-10 days | 7-10 days | |
| 10 µg | $183 | 7-10 days | 7-10 days | |
| 20 µg | $306 | 7-10 days | 7-10 days | |
| 50 µg | $517 | 7-10 days | 7-10 days | |
| 100 µg | $773 | 7-10 days | 7-10 days | |
| 200 µg | $1,160 | 7-10 days | 7-10 days | |
| 500 µg | $2,000 | 7-10 days | 7-10 days |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Bioactivity | Immobilized Human VEGF165 at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Human VEGFR2, mFc Tag with the EC50 of 42.3 ng/ml determined by ELISA. Human VEGF165 stimulates proliferation of human umbilical vein endothelial cells (HUVEC) with the ED50 for this effect is 2.57 ng/mL (QC Test). |
| Description | VEGF165 Protein, Human/Cynomolgus, Recombinant V2 is expressed in HEK293 Cells. The accession number is P15692-4. |
| Species | Human |
| Expression System | HEK293 Cells |
| Tag | Tag Free |
| Accession Number | P15692-4 |
| Construction | Ala27-Arg191 |
| Protein Purity | > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Reconstitute the lyophilized protein in sterile deionized water. The product concentration should not be less than 100 μg/mL. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
| Synonyms | VPF, VEGFA, VEGF, Vascular permeability factor, L-VEGF |
| Research Background | Human papillomavirus (HPV) infection is an established risk factor for cervical carcinogenesis. VEGF165 was significantly higher, whereas VEGFC and VEGFD were significantly lower in malignant cervical carcinoma tissues as compared to normal cervix tissues. Expression levels of VEGF121 and VEGFC were significantly associated with type of tumor growth while VEGF165 was significantly associated with lymph node metastasis. |
| Molecular Weight | 19.2 kDa (Predicted); 20-30 kDa (Due to glycosylation) |
| Shipping | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| Storage | Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Recombinant Proteins
Keywords
Preview
Related Tags: VEGF165 Protein, Human/Cynomolgus, Recombinant V2 chemical structure | VEGF165 Protein, Human/Cynomolgus, Recombinant V2 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.